Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Glioblastoma 8Neoplasms 4Brain Neoplasms 4Endometrial Neoplasms 3Breast Neoplasms 3Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pediatric Brain Tumor 1Ovarian Neoplasms 1Non-alcoholic Fatty Liver Disease 1Multiple Myeloma 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Kidney Neoplasms 1Ketogen-based Therapeutic Diet 1Intermittent Fasting 1Head and Neck Neoplasms 1Growth Hormone-Secreting Pituitary Adenoma 1Glioma 1Fatty Liver 1Estrogen Receptor-positive Breast Cancer 1Drug Resistant Epilepsy 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Autism Spectrum Disorder 1Adenocarcinoma of Lung 1

Interventions

palbociclib 2Letrozole 2Fulvestrant 2pyrotinib 1Trastuzumab 1Diet, Ketogenic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Estrogen Receptor-positive Breast Cancer × Diet, Ketogenic × Clear all
NCT03962647 2026-04-30

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Completed
31 enrolled
Breast

Estrogen Receptor-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡